Latest News in the pharma Industry

Research & Development

Sweeter treatment for breast and stomach cancers

Sweeter treatment for breast and stomach cancers

18 Jan 2016

Tweaking sugar molecules on anti-cancer antibodies improves cell-killing with fewer side effects.

Read more 
Centauri Therapeutics to develop novel anti-infective therapeutics

Centauri Therapeutics to develop novel anti-infective therapeutics

18 Jan 2016

Company has acquired Alphamer immuno-therapeutics platform technology.

Read more 
AbbVie announces positive top-line results from second Phase III study investigating Elagolix in patients with endometriosis

AbbVie announces positive top-line results from second Phase III study investigating Elagolix in patients with endometriosis

15 Feb 2016

Results show Elagolix reduces endometriosis-associated pain compared to placebo.

Read more 
Boehringer Ingelheim and Arena Pharmaceuticals collaborate to advance research in schizophrenia

Boehringer Ingelheim and Arena Pharmaceuticals collaborate to advance research in schizophrenia

14 Jan 2016

Collaboration partners to strengthen research in psychiatric diseases.

Read more 
Sanofi Pasteur provides key support to the Human Vaccines Project

Sanofi Pasteur provides key support to the Human Vaccines Project

14 Jan 2016

The research program is designed to accelerate the development of vaccines by decoding the human immune system.

Read more 
New NIH awards will support development of therapeutic alternatives to traditional antibiotics

New NIH awards will support development of therapeutic alternatives to traditional antibiotics

13 Jan 2016

NIAID awards approximately $5 million in funding for 24 research projects.

Read more 
FDA grants Priority Review for venetoclax NDA

FDA grants Priority Review for venetoclax NDA

12 Jan 2016

Venetoclax, an investigational medicine, is a potential new way of treating the most common adult leukemia.

Read more 
Scholar Rock announces option exercised by Janssen in immuno-oncology collaboration focused on supracellular activation

Scholar Rock announces option exercised by Janssen in immuno-oncology collaboration focused on supracellular activation

11 Jan 2016

Company generates unique monoclonal antibodies that selectively inhibit the supracellular activation of latent TGF-beta 1 in the immune system.

Read more 
HemoShear Therapeutics announces next stage of safety collaboration with Pfizer

HemoShear Therapeutics announces next stage of safety collaboration with Pfizer

11 Jan 2016

Development of a biological and computational model for prediction of drug-induced vascular injury for early-stage compounds.

Read more 
VR315 US completes clinical study

VR315 US completes clinical study

11 Jan 2016

VR315 is a generic, inhaled combination therapy for asthma/COPD delivered using Vectura's proprietary dry powder inhaler and formulation technology.

Read more 
Epigenomics receives FDA notification about status of pending approval decision for Epi proColon

Epigenomics receives FDA notification about status of pending approval decision for Epi proColon

8 Jan 2016

Final approval of the company's application is subject to the resolution of minor outstanding topics, such as the use of appropriate language in the product labeling.

Read more 
Regeneron and Sanofi announce sarilumab BLA Accepted for review by FDA

Regeneron and Sanofi announce sarilumab BLA Accepted for review by FDA

8 Jan 2016

Sarilumab is an investigational, human monoclonal antibody intended for the treatment of patients with active, moderate-to-severe rheumatoid arthritis

Read more